Thomas Armor

Efficacy and Safety of High-Specific-Activity ¹³¹I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Daniel A. Pryma, Bennett B. Chin, Richard B. Noto et al. · Journal of Nuclear Medicine · 2018 · 283 citations · Full text

Medicine, Oncology, Pharmacology +8

First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer

John Barrett, Robert E. Coleman, Stanley J. Goldsmith et al. · Journal of Nuclear Medicine · 2013 · 209 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +17

^99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer

Shankar Vallabhajosula, Anastasia Nikolopoulou, John W. Babich et al. · Journal of Nuclear Medicine · 2014 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095

Ali Afshar‐Oromieh, Uwe Haberkorn, Christian M. Zechmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 83 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase 2 Study of ^99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection

Karolien Goffin, Steven Joniau, Péter Tenke et al. · Journal of Nuclear Medicine · 2017 · 74 citations · Full text

Medicine, Nuclear Medicine, Urology +17